Content by The Alliance for Clinical Trials in Oncology
|2 min read
Pembrolizumab Shows Positive Results in Bladder Cancer Trial
Globally, there were around 573,000 new cases and 212,000 deaths from bladder cancer in 2020|2 min read
Bladder Cancer Treatment in Phase 3 Trial Shows Promise
It is estimated that approximately 82,290 people in the US will be diagnosed with bladder cancer in 2023|3 min read
Phase 3 Trial for Neuroendocrine Tumor Treatment Shows Promise
The safety profile of cabozantinib observed in the trial was consistent with its known safety profilePage 1 of 1






